Clinical Trial Update: Observe the Safety and Effectiveness of the WATCHMAN FLX™ for Subjects in Hong Kong

View source ↗

Summary

Clinical trial update indicating the WATCHMAN FLX left atrial appendage closure device was evaluated for safety and effectiveness in Hong Kong subjects with non…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-valvular Atrial Fibrillation

Drugs mentioned

• WATCHMAN FLX

Snippet

Sponsor: Boston Scientific Corporation | Conditions: Non-valvular Atrial Fibrillation | Status: COMPLETED | Results posted: 2024-08-12